Boston Scientific’s shares tumble 18% despite strong FY25 growth
Despite reporting revenue of $20bn in its fiscal year 2025 (FY25) and strong growth in Q4 2025, Boston Scientific’s shares…
05 Feb 2026
UK’s NICE greenlights Abbott’s CardioMEMS heart failure sensor
The UK’s National Institute for Health and Care Excellence (NICE) has recommended medtech giant Abbott’s heart failure sensor CardioMEMS. This means that the CE-marked medical device will be available for…
05 Feb 2026
Jupiter Endovascular completes SPIRARE II trial enrolment for Vertex system
Jupiter Endovascular has completed patient enrolment in the SPIRARE II pivotal clinical trial of its Vertex pulmonary embolectomy (PE) system, which uses transforming fixation (TFX) technology for endovascular interventions in…
05 Feb 2026
Hologic’s Aptima assay secures FDA approval for HPV primary screening
Hologic has received the US Food and Drug Administration (FDA) approval for its Aptima HPV assay for use in clinician-collected primary screening, further expanding its cervical health portfolio. The human…
04 Feb 2026
GE HealthCare reports FY25 revenue of $20.6bn amid strong imaging demand
GE HealthCare has achieved revenues of $20.6bn in fiscal year 2025 (FY25) amid ongoing imaging demand and now expects earnings to fall in the $4.95 to $5.15 per share range…
04 Feb 2026
MHRA outlines upcoming IVD submission shift for clinical trials
The Medicines and Healthcare products Regulatory Agency (MHRA) is formalising its review process around in vitro diagnostics (IVD) or companion diagnostics (CDx) used in clinical trials, with failure to comply…
04 Feb 2026
Medtronic set to acquire CathWorks for $585m
Medtronic has announced plans to exercise its option to acquire medical device company CathWorks, which is focused on transforming the diagnosis and treatment of coronary artery disease (CAD), for $585m.…